HB 1885 - DIGEST

Provides that the state investment board may not invest in a pharmaceutical manufacturing company that: (1) Restricts the supply of one or more prescription drugs to Canada in response to the reimportation of a prescription drug into the United States; or

(2) Sells any of their prescription drugs in the United States at a rate that is more than ten percent higher than the price they charge in Canada.